New Wave Of Cancer Drugs Puts Hard Focus On Need For Inexpensive Screening
This article was originally published in The Pink Sheet Daily
Executive Summary
Stunning advances in cancer therapies have sharpened the need for low-cost gene sequencing to identify the right patients for the right drugs, especially in Asia, frontline cancer experts say.
You may also be interested in...
Sanofi To Cut Drug Prices In South East Asia In Experiment Aimed At Creating A Sustainable Model Of Access
SHANGHAI - Sanofi-Aventis hopes to widen the availability of its medicines in less developed nations by slashing the price of some drugs in Southeast Asia, in a move that could be modeled after a similar program launched by GlaxoSmithKline one year ago
Roche Diagnostics’ Asia Pacific Managing Director Roland Diggelmann On Delivering Personalized Medicine: An Interview With PharmAsia News (Part 2 of 2)
Roche Diagnostics, world leaders in in vitro diagnostics, has identified Asia Pacific as its fastest-growing region. Among other Asia-Pac countries is India, which has been consistently growing at 30 percent for the company. Roland Diggelmann, Managing Director at Roche Diagnostics Asia Pacific told PharmAsia News that with a slew of product launches the region will continue to play a bigger role in the global plans of the company. Diggelmann, who has several countries like Australia, China, Hong Kong, India, Indonesia, Korea, Malaysia, New Zealand, Pakistan, Philippines, Singapore, Taiwan, Thailand, and Vietnam under his charge, discusses Roche's plans in this interview.
List Ahead For Southeast Asia Pharma In 2015
PharmAsia News looks ahead at 2015 to highlight expected trends and events shaping the biomedical community in Southeast Asia.